| Autor: |
Corine H. Geurts van Kessel, Nynke Y. Rots, Marjan Kuijer, Jeffrey van Vliet, Robert S. van Binnendijk, Eric R.A. Vos, Fiona R. M. van der Klis, Denise Wong, Hester E. de Melker, Lotus L. van den Hoogen, Alienke J. Wijmenga-Monsuur, Susanne P. Stoof, Adam Meijer, Lisa Wijsman, Daphne F.M. Reukers, Gerco den Hartog, Michiel van Boven, Chantal Reusken, Gaby Smits, Linde Woudstra, Cheyenne C E van Hagen |
| Rok vydání: |
2021 |
| Předmět: |
|
| DOI: |
10.1101/2021.10.05.21264555 |
| Popis: |
BackgroundWith COVID-19 vaccine roll-out ongoing in many countries globally, monitoring of breakthrough infections is of great importance. Antibodies persist in the blood after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Since COVID-19 vaccines induce immune response to the Spike protein of the virus, which is the main serosurveillance target to date, alternative targets should be explored to distinguish infection from vaccination.MethodsMultiplex immunoassay data from 1,513 SARS-CoV-2 RT-qPCR-tested individuals (352 positive and 1,161 negative) with a primary infection and no vaccination history were used to determine the accuracy of Nucleoprotein-specific immunoglobulin G (IgG) in detecting past SARS-CoV-2 infection. We also described Spike S1 and Nucleoprotein-specific IgG responses in 230 COVID-19 vaccinated individuals (Pfizer/BioNTech).ResultsThe sensitivity of Nucleoprotein seropositivity was 85% (95% confidence interval: 80-90%) for mild COVID-19 in the first two months following symptom onset. Sensitivity was lower in asymptomatic individuals (67%, 50-81%). Participants who had experienced a SARS-CoV-2 infection up to 11 months preceding vaccination, as assessed by Spike S1 seropositivity or RT-qPCR, produced 2.7-fold higher median levels of IgG to Spike S1 ≥14 days after the first dose as compared to those unexposed to SARS-CoV-2 at ≥7 days after the second dose (p=0.011). Nucleoprotein-specific IgG concentrations were not affected by vaccination in naïve participants.ConclusionsSerological responses to Nucleoprotein may prove helpful in identifying SARS-CoV-2 infections after vaccination. Furthermore, it can help interpret IgG to Spike S1 after COVID-19 vaccination as particularly high responses shortly after vaccination could be explained by prior exposure history. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
